X. LI
Observed name: X‐X Li
Institutions: F. Hoffmann-La Roche AG, Novartis (Switzerland), St George's Hospital, University Hospitals of Morecambe Bay NHS Foundation Trust, Shanxi Medical University, University of Toronto, University of Milan, Universidade de Santiago de Compostela, Tuen Mun Hospital, St George’s University Hospitals NHS Foundation Trust, Kingston Hospital NHS Trust, University of Alabama at Birmingham, Sorbonne Université, Vifor Pharma (Switzerland), Hôpital Saint-Antoine, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Second Hospital of Shanxi Medical University, Kingston Hospital, Complejo Hospitalario de Ourense, Celgene (Switzerland), UAB Medicine, Cilag (Switzerland), Roche Pharma (Schweiz) AG (Switzerland), Lancaster University, University of Brescia
Observed institutions: F. Hoffmann-La Roche AG, Novartis (Switzerland), St George's Hospital, Shandong University, University Hospitals of Morecambe Bay NHS Foundation Trust, Shanxi Medical University, University of Toronto, University of Milan, Universidade de Santiago de Compostela, Guangdong General Hospital, Tuen Mun Hospital, St George’s University Hospitals NHS Foundation Trust, Kingston Hospital NHS Trust, University of Alabama at Birmingham, Sorbonne Université, Vifor Pharma (Switzerland), Hôpital Saint-Antoine, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Mohamed I University, Second Hospital of Shanxi Medical University, Yantaishan Hospital, Kingston Hospital, Guangdong Academy of Medical Sciences, Qilu Hospital of Shandong University, Complejo Hospitalario de Ourense, Celgene (Switzerland), UAB Medicine, Cilag (Switzerland), Roche Pharma (Schweiz) AG (Switzerland), Lancaster University, University of Brescia
OpenAlex ID: A5032516487